DexCom (DXCM) gross profit was $2.8B in FY2025 (+15% YoY). The tables below show the complete quarterly and annual gross profit history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Gross Profit
Fiscal Year
Gross Profit
YoY
2025
$2.8B
+15%
2024
$2.4B
+7%
2023
$2.3B
+22%
2022
$1.9B
+12%
2021
$1.7B
+31%
2020
$1.3B
+37%
2019
$932M
+40%
2018
$664M
+35%
2017
$492M
+30%
2016
$378M
+36%
2015
$278M
+58%
2014
$176M
+76%
2013
$100M
+115%
2012
$47M
+30%
2011
$36M
+95%
2010
$18M
+403%
2009
$4M
Recent Quarterly Gross Profit
Quarter
Gross Profit
Q1 2026
$750M
Q4 2025
$793M
Q3 2025
$731M
Q2 2025
$689M
Q1 2025
$589M
Q4 2024
$656M
Q3 2024
$594M
Q2 2024
$627M
Q1 2024
$562M
Q4 2023
$657M
Q3 2023
$623M
Q2 2023
$546M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.